⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
U.S. Orphan Drug Market Report 2026: A $200 Billion Opportunity by 2031 - Indication, Company, Trial Phase, Marketed Status of 1400 Drugs, Drug Sales of 150 Drugs, Pricing and Dosage of 400 Drugs
globenewswire.com
BMY
GILD
JNJ
SNY
TAK
AMGN
AZN
LLY
MRK
PFE
REGN
VRTX
ABBV
ALNY
AMTX
BIIB
BMRN
CRSP
EXAS
INCY
IONS
JAZZ
NTLA
PTC
RGEN
XOM
Conjunctivitis Market to Reach $61.6 Billion by 2033 Globally, at 13.8% CAGR: Allied Market Research
prnewswire.com
ABBV
JNJ
BHC
NVS
Genmab Publishes 2025 Annual Report
globenewswire.com
GMAB
HALO
ABBV
MRUS
NVS
JNJ
HRZN
Intraocular Lens Market Poised for Strong Growth as Rising Cataract Procedures and Premium Vision Correction Demand Accelerate: Verified Market Research®
prnewswire.com
ALC
BHC
JNJ
SGA
ABT
Stella Mental Health Expands Boston-Area Services with New Newton Clinic as Chief Psychiatric Officer Dr. Brian Boyle Selected as 2026 National SPRAVATO® Bureau Speaker
prnewswire.com
JNJ
Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A
globenewswire.com
SUPN
MGTX
JNJ
ARWR
FDA approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month
prnewswire.com
JNJ
CAR T-Cell Therapy Market worth $13.78 billion by 2031 | MarketsandMarkets™
prnewswire.com
BMY
GILD
JNJ
CRSP
ALLO
CART
Nucleome Therapeutics appoints experienced biotech executive Dr. Michelle Morrow as Chief Scientific Officer
prnewswire.com
JNJ
PFE
Philadelphia Jury Returns $250,000 Verdict Against J&J in Latest Baby Powder-Ovarian Cancer Trial
businesswire.com
JNJ